ABIN317554
antibody from antibodies-online
Targeting: FOLH1
FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN317554 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Folate Hydrolase (Prostate-Specific Membrane Antigen) 1 (FOLH1) (AA 117-351) antibody
- Antibody type
- Monoclonal
- Description
- Protein-G affinity chromatography
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 117-351
- Isotype
- IgG
- Antibody clone number
- k1H7
- Vial size
- 0.1 mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing.Shelf life: one year from despatch.
Submitted references Prostate-specific membrane antigen associates with anaphase-promoting complex and induces chromosomal instability.
Induction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccination.
Targeting novel antigens for prostate cancer treatment: focus on prostate-specific membrane antigen.
Rajasekaran SA, Christiansen JJ, Schmid I, Oshima E, Ryazantsev S, Sakamoto K, Weinstein J, Rao NP, Rajasekaran AK
Molecular cancer therapeutics 2008 Jul;7(7):2142-51
Molecular cancer therapeutics 2008 Jul;7(7):2142-51
Induction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccination.
Gregor PD, Wolchok JD, Turaga V, Latouche JB, Sadelain M, Bacich D, Heston WD, Houghton AN, Scher HI
International journal of cancer. Journal international du cancer 2005 Sep 1;116(3):415-21
International journal of cancer. Journal international du cancer 2005 Sep 1;116(3):415-21
Targeting novel antigens for prostate cancer treatment: focus on prostate-specific membrane antigen.
Slovin SF
Expert opinion on therapeutic targets 2005 Jun;9(3):561-70
Expert opinion on therapeutic targets 2005 Jun;9(3):561-70
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC